IFNG and neoplasm: The phenotype of TANs can be divided into two distinct subsets (N1 and N2), with the anti-tumor N1 type modulating IFN-γ while the tumor-promoting N2 type regulating TGF-β; the N2 type is the major subtype observed in the TME (114).